Imatinib Completed Phase 2 Trials for Agnogenic Myeloid Metaplasia / Chronic Myelomonocytic Leukemia / Myeloid Metaplasia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00136409A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)